Pure Global

Direct Bilirubin - India CDSCO Medical Device Registration

Direct Bilirubin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2018/000029_de87e990dd1cf4ee1cc10bc45eddd7af_ae0ef5e8a7fc5709f77a2b9477afb27c. This device is marketed under the brand name Alinity c Ultra HDL Reagent Kit. The license holder is Abbott Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Direct Bilirubin
UID: IMP/IVD/2018/000029_de87e990dd1cf4ee1cc10bc45eddd7af_ae0ef5e8a7fc5709f77a2b9477afb27c

Brand Name

Alinity c Ultra HDL Reagent Kit

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Direct Bilirubin assay is used for the quantitative analysis of direct bilirubin in human serum or plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing